双歧杆菌四联活菌片防治婴幼儿肺炎继发性腹泻效果观察

Observational study of bifidobacterium tetravaccine tablets in prevention and cure diarrhea complication in pediatric pneumonia cases

目的:探讨双歧杆菌四联活菌片防治婴幼儿肺炎继发性腹泻效果。方法:将146例婴幼儿肺炎患儿随机分为2组,预防组86例,对照组60例。2组均予抗生素治疗,预防组予双歧杆菌四联活菌片口服,然后对2组继发性腹泻的发病率、疗效进行统计分析。结果:预防组继发腹泻17例,发病率为19.8%,对照组继发腹泻28例,发病率46.7%(2χ=11.99,P<0.01)。预防组治疗婴幼儿肺炎继发性腹泻的疗效明显优于对照组(2χ=21.93,P<0.01)。结论:双歧杆菌四联活菌片能降低婴幼儿肺炎继发性腹泻的发病率,在治疗肺炎的同时预防性应用,具有良好的效果。

Objective： To explore the effect of Bifidobacterium tetravaccine tablets （Live） in prevention and cure diarrhea complication in pneumonia children. Methods：Totally 146 inpatients with pediatric pneumonia were divided randomly into 86 in experimental group and 60 in contrast group, the experimental group were treated with Bifidobacterium tetravaccine tablets（Live）. Other treatments including using antibiotics were not different. The subsequent diarrhea occurrence rate and efficacy were compared between the two groups. Results ： Altogether 17 cases of the experimental group occurred diarrhea , with the incidence of 19.8 % ; 28 cases of the contrast group occurred diarrhea , with the incidence of 46.7 %. There showed statistical significant differences between the two groups （χ^2 = 11. 99, P 〈 0.01 ）. The diarrhea control showed significant difference too （χ^2 = 21.93, P 〈 0.01 ）. Conclusion ： Bifidobacterium tetravaccine tablets （Live） can efficiently prevention and cure diarrhea complication in pediatric pneumonia.